Retinal drusen in glomerulonephritis with or without immune deposits suggest systemic complement activation in disease pathogenesis

[1]  R. Stahl,et al.  Is primary membranous nephropathy a complement mediated disease? , 2020, Molecular immunology.

[2]  S. Krieger,et al.  ECM Characterization Reveals a Massive Activation of Acute Phase Response during FSGS , 2020, International journal of molecular sciences.

[3]  P. Cravedi,et al.  Complement and Complement Targeting Therapies in Glomerular Diseases , 2019, International journal of molecular sciences.

[4]  Yichun Hu,et al.  Measuring Circulating Complement Activation Products in Myeloperoxidase– and Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis , 2019, Arthritis & rheumatology.

[5]  Y. Caliskan,et al.  Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis , 2019, Kidney and Blood Pressure Research.

[6]  H. Başmak,et al.  Perimacular drusenoid deposits in a child with IgA nephropathy. , 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[7]  D. Galimberti,et al.  Drusen-like Deposits in Young Adults Diagnosed With Systemic Lupus Erythematosus. , 2017, American journal of ophthalmology.

[8]  D. Colville,et al.  Retinal disease in the C3 glomerulopathies and the risk of impaired vision , 2016, Ophthalmic genetics.

[9]  Ivana K. Kim,et al.  A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants , 2015, Nature Genetics.

[10]  D. Gipson,et al.  Complement Activation in Patients with Focal Segmental Glomerulosclerosis , 2015, PloS one.

[11]  G. Abecasis,et al.  Age-related macular degeneration: genetics and biology coming together. , 2014, Annual review of genomics and human genetics.

[12]  C. Baumal,et al.  Subretinal drusenoid deposits associated with complement-mediated IgA nephropathy. , 2014, JAMA ophthalmology.

[13]  T. Schall,et al.  C5a receptor (CD88) blockade protects against MPO-ANCA GN. , 2014, Journal of the American Society of Nephrology : JASN.

[14]  J. Thurman,et al.  IgM contributes to glomerular injury in FSGS. , 2013, Journal of the American Society of Nephrology : JASN.

[15]  R. Falk,et al.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. , 2013, Annual review of pathology.

[16]  Richard J. H. Smith,et al.  Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  D. Power,et al.  Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[18]  P. Heeringa,et al.  Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. , 2007, Kidney international.

[19]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[21]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  S. Russell,et al.  Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. , 2000, American journal of ophthalmology.

[23]  M. Killingsworth,et al.  Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.

[24]  T. Fujita,et al.  Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  J. H. Jansen,et al.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. , 1995, The Journal of clinical investigation.

[26]  R. Klein,et al.  The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.

[27]  N. McKechnie,et al.  Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. , 1989, The British journal of ophthalmology.

[28]  R. Tubbs,et al.  Focal and segmental glomerulosclerosis. Immunohistologic study of 20 renal biopsy specimens. , 1986, Archives of pathology & laboratory medicine.

[29]  D. Salant,et al.  Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. , 1986, The Journal of clinical investigation.

[30]  Y. Hamashima,et al.  Distribution of IgG subclasses in membranous nephropathy. , 1984, Clinical and experimental immunology.

[31]  D. Archer,et al.  Familial and secondary drusen: histologic and functional correlations. , 1971, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.

[32]  Ivana K. Kim,et al.  Genetics of age-related macular degeneration (AMD). , 2017, Human molecular genetics.

[33]  M. A. Sheddi.  A clinicopathological study , 2012 .

[34]  P. Heeringa,et al.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. , 2007, The American journal of pathology.

[35]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.